206 related articles for article (PubMed ID: 23591345)
1. [X-linked inhibitor of apoptosis protein (XIAP) and Survivin suppression on human pancreatic cancer cells Panc-1 proliferation and chemosensitivety].
Zai HY; Yi XP; Li YX; You XY; Cao LP; Liu H
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):242-9. PubMed ID: 23591345
[TBL] [Abstract][Full Text] [Related]
2. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
Jiang C; Yi XP; Shen H; Li YX
World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.
Yang J; Ouyang J; Ouyang L; Ouyang L; Chen Y
Oncol Res; 2013; 21(1):43-50. PubMed ID: 24330851
[TBL] [Abstract][Full Text] [Related]
4. [Simultaneous inhibition of XIAP and survivin expression on EMT and invasion of human pancreatic cancer cells].
Zai H; Yi X; Li Y; Jiang C; Lu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):883-8. PubMed ID: 23000761
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway.
Yi XP; Han T; Li YX; Long XY; Li WZ
Mol Med Rep; 2015 Jul; 12(1):601-8. PubMed ID: 25707849
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.
Galloway NR; Aspe JR; Sellers C; Wall NR
Pancreas; 2009 Oct; 38(7):782-90. PubMed ID: 19506533
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated shRNA targeting XIAP and survivin inhibit SW1990 pancreatic cancer cell proliferation in vitro and in vivo.
Jiang C; Tan T; Yi XP; Shen H; Li YX
Mol Med Rep; 2011; 4(4):667-74. PubMed ID: 21479361
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
[TBL] [Abstract][Full Text] [Related]
9. Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
Dizdar L; Oesterwind KA; Riemer JC; Werner TA; Mersch S; Möhlendick B; Schütte SC; Verde PE; Raba K; Topp SA; Stoecklein NH; Esposito I; Knoefel WT; Krieg A
Oncotarget; 2017 Jan; 8(5):8369-8382. PubMed ID: 28039474
[TBL] [Abstract][Full Text] [Related]
10. Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
Guo HC; Bu HQ; Luo J; Wei WT; Liu DL; Chen H; Tong HF; Wang ZH; Wu HY; Li HH; Zuo MM; Li W; Lin SZ
Int J Oncol; 2012 Jun; 40(6):1849-57. PubMed ID: 22378302
[TBL] [Abstract][Full Text] [Related]
11. Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression.
Fei B; Chi AL; Weng Y
World J Surg Oncol; 2013 May; 11():120. PubMed ID: 23721525
[TBL] [Abstract][Full Text] [Related]
12. YM155 induces EGFR suppression in pancreatic cancer cells.
Na YS; Yang SJ; Kim SM; Jung KA; Moon JH; Shin JS; Yoon DH; Hong YS; Ryu MH; Lee JL; Lee JS; Kim TW
PLoS One; 2012; 7(6):e38625. PubMed ID: 22723871
[TBL] [Abstract][Full Text] [Related]
13. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
[TBL] [Abstract][Full Text] [Related]
14. [Effect of survivin targeting on cell proliferation and apoptosis in pancreatic cancer cells].
Dai DJ; Lu CD; Lai RY; Guo JM; Meng H
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1894-8. PubMed ID: 15631802
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
16. Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells.
Shrikhande SV; Kleeff J; Kayed H; Keleg S; Reiser C; Giese T; Büchler MW; Esposito I; Friess H
Anticancer Res; 2006; 26(5A):3265-73. PubMed ID: 17094439
[TBL] [Abstract][Full Text] [Related]
17. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
18. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
19. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
[TBL] [Abstract][Full Text] [Related]
20. The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549.
Liang H; Wang HB; Liu HZ; Wen XJ; Zhou QL; Yang CX
Biomed Pharmacother; 2013 Jul; 67(6):503-9. PubMed ID: 23639227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
